1887

Microbiology Society logo

Volume 150, Issue 5

Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37 °C and Free

Abstract

Acetolactate synthase catalyses the first common step in isoleucine and valine biosynthesis and is the target of several classes of inhibitors. The gene, encoding acetolactate synthase, was identified by complementation of a mutant. is highly resistant to the commercially available acetolactate synthase inhibitor, sulfometuron methyl (SM). Expression of in conferred SM resistance, indicating that the SM resistance of is due, at least in part, to Ilv2p. The gene was disrupted. The mutants were auxotrophic for isoleucine and valine and the auxotrophy was satisfied by these amino acids only when proline, and not ammonium, was the nitrogen source, indicating nitrogen regulation of amino acid transport. mutants rapidly lost viability at 37 °C and when starved for isoleucine and valine. Consistent with these phenotypes, an mutant was avirulent and unable to survive in mice. Because Ilv2p is required for virulence and survival , inhibitors of branched-chain amino acid biosynthesis may make valuable antifungal agents.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): Nat, nourseothricin and SM, sulfometuron methyl
SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.26928-0
2004-05-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/150/5/mic1501547.html?itemId=/content/journal/micro/10.1099/mic.0.26928-0&mimeType=html&fmt=ahah

References

  1. Becker J. M., Naider F. 1977; Peptide transport in yeast: uptake of radioactive trimethionine in Saccharomyces cerevisiae. Arch Biochem Biophys 178:245–255 [CrossRef]
     [Google Scholar]
  2. Brandt M. E., Bragg S. L., Pinner R. W. 1993; Multilocus enzyme typing of Cryptococcus neoformans. J Clin Microbiol 31:2819–2823
     [Google Scholar]
  3. Bulmer G. S., Sans M. D., Gunn C. M. 1967; Cryptococcus neoformans. I. Nonencapsulated mutants. J Bacteriol 94:1475–1479
     [Google Scholar]
  4. Casadevall A., Perfect J. R. 1998 Cryptococcus neoformans Washington, DC: American Society for Microbiology;
     [Google Scholar]
  5. Chang Y. C., Kwon-Chung K. J. 1994; Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14:4912–4919
     [Google Scholar]
  6. Chipman D., Barak Z., Schloss J. V. 1998; Biosynthesis of 2-aceto-2-hydroxy acids: acetolactate synthases and acetohydroxyacid synthases. Biochim Biophys Acta 1385401–419 [CrossRef]
     [Google Scholar]
  7. Cox G. M., Mukherjee J., Cole G. T., Casadevall A., Perfect J. R. 2000; Urease as a virulence factor in experimental cryptococcosis. Infect Immun 68:443–448 [CrossRef]
     [Google Scholar]
  8. Davidson R. C., Blankenship J. R., Kraus P. R., de Jesus Berrios M., Hull C. M., D'Souza C., Wang P., Heitman J. 2002; A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology 148:2607–2615
     [Google Scholar]
  9. Duggleby R. G., Pang S. S., Yu H., Guddat L. W. 2003; Systematic characterization of mutations in yeast acetohydroxyacid synthase. Interpretation of herbicide-resistance data. Eur J Biochem 270:2895–2904 [CrossRef]
     [Google Scholar]
  10. Falco S. C., Dumas K. S. 1985; Genetic analysis of mutants of Saccharomyces cerevisiae resistant to the herbicide sulfometuron methyl. Genetics 109:21–35
     [Google Scholar]
  11. Falco S. C., Dumas K. S., Livak K. J. 1985; Nucleotide sequence of the yeast ILV2 gene which encodes acetolactate synthase. Nucleic Acids Res 13:4011–4027 [CrossRef]
     [Google Scholar]
  12. Falco S. C., McDevitt R. E., Chui C.-F., Hartnett M. E., Knowlton S., Mauvais C. J., Smith J. K., Mazur B. J. 1989; Engineering herbicide-resistant acetolactate synthase. Dev Ind Microbiol 30:187–194
     [Google Scholar]
  13. Fromtling R. A., Shadomy H. J., Jacobson E. S. 1982; Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79:23–29 [CrossRef]
     [Google Scholar]
  14. Gietz R. D., Schiestl R. H., Willems A. R., Woods R. A. 1995; Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355–360 [CrossRef]
     [Google Scholar]
  15. Goldstein A. L., McCusker J. H. 1999; Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15:1541–1553 [CrossRef]
     [Google Scholar]
  16. Goldstein A. L., McCusker J. H. 2001; Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment. Genetics 159:499–513
     [Google Scholar]
  17. Grandoni J. A., Marta P. T., Schloss J. V. 1998; Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents. J Antimicrob Chemother 42:475–482 [CrossRef]
     [Google Scholar]
  18. Heitman J., Allen B., Alspaugh J. A., Kwon-Chung K. J. 1999; On the origins of congenic MATα and MATa strains of the pathogenic yeast Cryptococcus neoformans. Fungal Genet Biol 28:1–5 [CrossRef]
     [Google Scholar]
  19. Hoffman C. S., Winston F. 1987; A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:265–272
     [Google Scholar]
  20. Kwon-Chung K. J., Bennett J. E. 1992 Medical Mycology Philadelphia: Lea & Febiger;
  21. Kwon-Chung K. J., Rhodes J. C. 1986; Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 51:218–223
     [Google Scholar]
  22. Kwon-Chung K. J., Edman J. C., Wickes B. L. 1992; Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun 60:602–605
     [Google Scholar]
  23. LaRossa R. A., Schloss J. V. 1984; The sulfonylurea herbicide sulfometuron methyl is an extremely potent and selective inhibitor of acetolactate synthase in Salmonella typhimurium. J Biol Chem 259:8753–8757
     [Google Scholar]
  24. LaRossa R. A., Van Dyk T. K. 1987; Metabolic mayhem caused by 2-ketoacid imbalances. Bioessays 7:125–130 [CrossRef]
     [Google Scholar]
  25. LaRossa R. A., Van Dyk T. K., Smulski D. R. 1987; Toxic accumulation of α-ketobutyrate caused by inhibition of the branched-chain amino acid biosynthetic enzyme acetolactate synthase in Salmonella typhimurium. J Bacteriol 169:1372–1378
     [Google Scholar]
  26. Logan D. A., Becker J. M., Naider F. 1979; Peptide transport in Candida albicans. J Gen Microbiol 114:179–186 [CrossRef]
     [Google Scholar]
  27. Manning M., Snoddy C. B., Fromtling R. A. 1984; Comparative pathogenicity of auxotrophic mutants of Candida albicans. Can J Microbiol 30:31–35 [CrossRef]
     [Google Scholar]
  28. McDade H. C., Cox G. M. 2001; A new dominant selectable marker for use in Cryptococcus neoformans. Med Mycol 39:151–154 [CrossRef]
     [Google Scholar]
  29. Mitchell T. G., Perfect J. R. 1995; Cryptococcosis in the era of AIDS – 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8:515–548
     [Google Scholar]
  30. Namiki F., Matsunaga M., Okuda M., Inoue I., Nishi K., Fujita Y., Tsuge T. 2001; Mutation of an arginine biosynthesis gene causes reduced pathogenicity in Fusarium oxysporum f. sp. melonis. Mol Plant–Microbe Interact 14:580–584 [CrossRef]
     [Google Scholar]
  31. Nisbet T. M., Payne J. W. 1979; Peptide uptake in Saccharomyces cerevisiae: characteristics of transport system shared by dipeptides and tripeptides. J Gen Microbiol 115:127–133 [CrossRef]
     [Google Scholar]
  32. Odom A., Muir S., Lim E., Toffaletti D. L., Perfect J., Heitman J. 1997; Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 16:2576–2589 [CrossRef]
     [Google Scholar]
  33. Pang S. S., Guddat L. W., Duggleby R. G. 2003; Molecular basis of sulfonylurea herbicide inhibition of acetohydroxyacid synthase. J Biol Chem 278:7639–7644 [CrossRef]
     [Google Scholar]
  34. Payne J. W., Barrett-Bee K. J., Shallow D. A. 1991; Peptide substrates rapidly modulate expression of dipeptide and oligopeptide permeases in Candida albicans. FEMS Microbiol Lett 79:15–20 [CrossRef]
     [Google Scholar]
  35. Perfect J. R., Toffaletti D. L., Rude T. H. 1993; The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect Immun 61:4446–4451
     [Google Scholar]
  36. Salas S. D., Bennett J. E., Kwon-Chung K. J., Perfect J. R., Williamson P. R. 1996; Effect of the laccase gene CNLAC1 on virulence of Cryptococcus neoformans. J Exp Med 184:377–386 [CrossRef]
     [Google Scholar]
  37. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  38. Schmeding K. A., Jong S. C., Hugh R. 1981; Sexual compatibility between serotypes of Filobasidiella neoformans (Cryptococcus neoformans). Curr Microbiol 5:133–138 [CrossRef]
     [Google Scholar]
  39. Sherman F., Fink G. R., Lawrence C. W. 1974 Methods in Yeast Genetics Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  40. Smith M., Jessee J., Landers T., Jordan J. 1990; High efficiency bacterial electroporation: 1×1010 E. coli transformants/μg. Focus 12:38–40
     [Google Scholar]
  41. Stetter J. 1994 Herbicides Inhibiting Branched Chain Amino Acid Biosynthesis – Recent Developments Berlin & New York: Springer;
  42. Suvarna K., Bartiss A., Wong B. 2000; Mannitol-1-phosphate dehydrogenase from Cryptococcus neoformans is a zinc-containing long-chain alcohol/polyol dehydrogenase. Microbiology 146:2705–2713
     [Google Scholar]
  43. Toffaletti D. L., Rude T. H., Johnston S. A., Durack D. T., Perfect J. R. 1993; Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175:1405–1411
     [Google Scholar]
  44. Torres-Guererro H., Edman J. C. 1994; Melanin-deficient mutants of Cryptococcus neoformans. J Med Vet Mycol 32:303–313 [CrossRef]
     [Google Scholar]
  45. Van Dyk T. K., Smulski D. R., Chang Y. Y. 1987; Pleiotropic effects of poxA regulatory mutations of Escherichia coli and Salmonella typhimurium, mutations conferring sulfometuron methyl and α-ketobutyrate hypersensitivity. J Bacteriol 169:4540–4546
     [Google Scholar]
  46. Williamson P. R. 1997; Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front Biosci 2:e99–e107
     [Google Scholar]
  47. Xie Q., Jimenez A. 1996; Molecular cloning of a novel allele of SMR1 which determines sulfometuron methyl resistance in Saccharomyces cerevisiae. FEMS Microbiol Lett 137:165–168 [CrossRef]
     [Google Scholar]
  48. Yang Z., Pascon R. C., Alspaugh A., Cox G. M., McCusker J. H. 2002; Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology 148:2617–2625
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.26928-0
Loading
Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37 °C and in vivo
Microbiology 150, 1547 (2004); https://doi.org/10.1099/mic.0.26928-0
/content/journal/micro/10.1099/mic.0.26928-0
/content/journal/micro/10.1099/mic.0.26928-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error